Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 4:26 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 80 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: PEG3350 Clear all

Conditions: Constipation
Interventions: Naloxegol Oral Tablet, Placebo Oral Tablet, Docusate Sodium 100 Mg oral capsule [Colace], Senna 217 Mg Oral Tablet, Polyethylene Glycols, Bisacodyl 10 mg Suppository, Magnesium Citrate Oral Liquid Product, Methylnaltrexone; Drug
Lead sponsor: Tufts Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Bowel Preparation
Interventions: NuLYTELY® (PEG 3350), ECP-019, MoviPrep® (PEG 3350); Drug
Lead sponsor: ColonaryConcepts LLC; Industry
Eligibility: 18 Years to 74 Years
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 2
States / cities: Indianapolis, Indiana • Lebanon, New Hampshire

Conditions: Opioid Induced Constipation
Interventions: Polyethylene Glycol 3350, Movantik; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 84 Years
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 53
States / cities: Huntsville, Alabama • Phoenix, Arizona • Anaheim, California + 46 more

Conditions: PTSD
Interventions: CBT + ImRs, CBT + I.E., D-Cycloserine, Placebo, Study Pill; Behavioral · Drug
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Colonoscopy
Interventions: Golytely (polyethylene glycol), MiraLax (polyethylene glycol 3350); Drug
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 50 Years to 90 Years
Enrollment: 432 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Coronary Artery Disease, Atherosclerosis, Inflammation, Endothelial Dysfunction
Interventions: Rilonacept, Placebo; Drug
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Constipation
Interventions: PEG3350; Drug
Lead sponsor: Braintree Laboratories; Industry
Eligibility: 4 Years to 16 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 2
States / cities: Little Rock, Arkansas • Morristown, New Jersey

Conditions: Autism Spectrum Disorder, Gastro-Intestinal Disorder, Constipation, Diarrhea
Interventions: MTP-101P, Vancomycin, Miralax, Antacid, Placebo MTP-101P, Placebo Vancomycin; Combination Product
Lead sponsor: Gut-Brain-Axis Therapeutics Inc.; Other
Eligibility: 4 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Infection, Human Immunodeficiency Virus, HIV Infections
Interventions: Cabotegravir (CAB) tablet, Rilpivirine (RPV) tablet, Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine - Injectable Suspension (RPV LA), 2 NRTIs plus an INI, NNRTI, or PI; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 618 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2029
U.S. locations: 36
States / cities: Birmingham, Alabama • Phoenix, Arizona • Bakersfield, California + 28 more

Conditions: Colonoscopy
Interventions: BLI-800, Polyethylene glycol 3350 based bowel preparation; Drug
Lead sponsor: Braintree Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 11
States / cities: Mobile, Alabama • Washington D.C., District of Columbia • Jupiter, Florida + 8 more

Conditions: Bowel Preparation for Colonoscopy
Interventions: MiraLAX, Gatorade, MoviPrep, SUPREP; Drug · Other
Lead sponsor: Gastroenterology Services, Ltd.; Other
Eligibility: 18 Years and older
Enrollment: 1,079 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Downers Grove, Illinois

Conditions: Pain, BPH With Urinary Obstruction, BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms
Interventions: Ibuprofen 600 mg, Education; Drug · Behavioral
Lead sponsor: Benaroya Research Institute; Other
Eligibility: 18 Years and older · Male only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Constipation
Interventions: Polyethylene Glycol 3350; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Female only
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Colonoscopy, Bowel Preparation, Endoscopy
Interventions: PEG-3350 based bowel preparation, BLI800 approved preparation regimen, BLI800 investigational preparation regimen; Drug
Lead sponsor: Braintree Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 541 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 17
States / cities: Mobile, Alabama • Anaheim, California • Jacksonville, Florida + 13 more

Conditions: Preparation for Colonoscopy
Interventions: Bowel Preparation; Drug
Lead sponsor: Gastroenterology Services, Ltd.; Other
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Downers Grove, Illinois

Conditions: Crohn's Disease
Interventions: Pillcam colon capsule and PillCam™ Prep Procedure, Ileocolonoscopy; Other · Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Hepatic Encephalopathy, HE, Cirrhosis, Altered Mental Status, AMS
Interventions: Lactulose, Polyethylene Glycol 3350; Drug
Lead sponsor: New York Presbyterian Brooklyn Methodist Hospital; Other
Eligibility: 18 Years to 80 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Colonoscopy
Interventions: Simethicone Solution, Water; Drug
Lead sponsor: University of Nevada, Reno; Other
Eligibility: 18 Years to 80 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 2
States / cities: Reno, Nevada

Conditions: Autism Spectrum Disorder, Gastro-Intestinal Disorder, Constipation, Diarrhea
Interventions: vancomycin, Miralax, intestinal microbiota, placebo vancomycin, Miralax, placebo intestinal microbiota; Combination Product
Lead sponsor: Arizona State University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Cystic Fibrosis Gastrointestinal Disease
Interventions: Polyethylene Glycol 3350, SmartPill Motility System & PillCam Patency Capsule; Drug · Device
Lead sponsor: St. Louis University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: St Louis, Missouri

Conditions: Colonoscopy
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 5 Years to 21 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Colon Prep for Colonoscopy
Interventions: ECP Colon Prep Kit, MoviPrep®; Drug
Lead sponsor: Sebela Pharmaceuticals Development LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 8
States / cities: Anaheim, California • Indianapolis, Indiana • Bastrop, Louisiana + 5 more

Conditions: Colonoscopy
Interventions: Magnesium Citrate Capsules, Polyethylene Glycol 3350, Dulcolax Tablets; Dietary Supplement · Other
Lead sponsor: LifeBridge Health; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Colonoscopy
Interventions: HalfLytely, NuLytely; Drug
Lead sponsor: Braintree Laboratories; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Timeline: Started 1999
U.S. locations: 2
States / cities: Braintree, Massachusetts • San Antonio, Texas

Search by objective public record fields.

Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids

Safety and Tolerability Study of an Edible Colon Preparation

To Evaluate Patient Preference of Movantik and Polyethylene Glycol 3350 for Opioid Induced Constipation

Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD

A Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus Golytely

Rilonacept to Improve Artery Function in Patients With Atherosclerosis

A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children

Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders

Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-acting Cabotegravir Plus Long-acting Rilpivirine From Current Antiretroviral Regimen in Virologically Suppressed HIV-1-infected Adults

BLI-800-301: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

A Comparison of 5 Low Volume Bowel Preparations

Optimizing Pain Control in Transurethral Resection of the Prostate

Bowel Function After Minimally Invasive Hysterectomy

A Safety Study of 3 Different Bowel Cleansing Preparations

Safety and Efficacy of High Dose Bowel Preparation Solutions for Patients With Difficult To Clean Colons For Colonoscopy

PillCam® Platform With the PillCam Crohn's Disease Capsule

Hepatic Encephalopathy: Lactulose or Polyethylene Glycol (H.E.L.P.)

Evaluation of Oral Simethicone With Low Volume Polyethylene Glycol Bowel Preparation During Colonoscopy

MTT for Children With ASD Who Have Gastrointestinal Disorders

Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit

The Efficacy Side Effects and the Tolerance of Polyethylene Glycol 3350 as a Bowel Prep in Children

Safety and Efficacy Study of an Edible Colonoscopy Preparation

Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy

HalfLytely Bowel Prep System for Colonoscopy